Envisioning the future of early anticancer drug development

被引：0

作者：

Timothy A. Yap

Shahneen K. Sandhu

Paul Workman

Johann S. de Bono

机构：

[1] Timothy A. Yap,

[2] Shahneen K. Sandhu and Johann S. de Bono are at the Drug Development Unit,undefined

[3] Royal Marsden NHS Foundation Trust,undefined

[4] Downs Road,undefined

[5] Sutton,undefined

[6] Surrey,undefined

[7] SM2 5PT,undefined

[8] United Kingdom.,undefined

[9] Timothy A. Yap,undefined

[10] Shahneen K. Sandhu,undefined

[11] Paul Workman and Johann S. de Bono are at the Section of Medicine and Cancer Research UK Centre for Cancer Therapeutics,undefined

[12] The Institute of Cancer Research,undefined

[13] 15 Cotswold Road,undefined

[14] Sutton,undefined

[15] Surrey SM2 5NG,undefined

[16] United Kingdom.,undefined

来源：

Nature Reviews Cancer | 2010年 / 10卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

There is an urgent need to accelerate the development of new molecularly targeted cancer therapeutics by improving early clinical anticancer drug evaluation. This article discusses current approaches and new strategies that should maximize benefit to patients and expedite the regulatory approval of new anticancer drugs.

引用

下载

页码：514 / 523

页数：9

共 50 条

[41] NOGALAMYCIN TO MENOGAROL - DEVELOPMENT OF AN ANTICANCER DRUG
BHUYAN, BK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1983, 186 (AUG): : 51 - MBTD
[42] PHARMACOGENOMICS : APPLICATIONS IN ANTICANCER DRUG DEVELOPMENT
Dutta, Rahul
Malakar, Dhruba
Sinha, Dipak
Khate, Keviletsu
Garg, Sweta
EVERYMANS SCIENCE, 2011, 46 (02): : 82 - 85
[43] Drug Repurposing in the Development of Anticancer Agents
Olgen, Sureyya
Kotra, Lakshmi
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (28) : 5410 - 5427
[44] The role of pharmacology in anticancer drug development
Peters, Godefridus J.
Govaerts, Anne-Sophie
Hendriks, Hans R.
ADMET AND DMPK, 2018, 6 (01): : 4 - 14
[45] Drug Repurposing in Anticancer Reagent Development
Chen, Peng-chen
Liu, Xiaolong
Lin, Yao
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017, 20 (05) : 395 - 402
[46] Lead Phytochemicals for Anticancer Drug Development
Singh, Sukhdev
Sharma, Bhupender
Kanwar, Shamsher S.
Kumar, Ashok
FRONTIERS IN PLANT SCIENCE, 2016, 7
[47] TOXICOLOGY RELEVANT TO ANTICANCER DRUG DEVELOPMENT
HARRAP, KR
INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 112 - 112
[48] Anticancer Drug Development: Evaluative Architecture
Lu, Da-Yong
Xu, Bin
Lu, Ting-Ren
LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (05) : 836 - 846
[49] Anticancer drug development: the grand challenges
Hait, William N.
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (04) : 253 - 254
[50] SIGNALING TARGETS FOR ANTICANCER DRUG DEVELOPMENT
POWIS, G
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (05) : 188 - 194

← 1 2 3 4 5 →